A double-blind, placebo-controlled trial of alprostadil/lidocaine [NM100061, NM 02216] for the treatment of premature ejaculation.
Phase of Trial: Phase II
Latest Information Update: 05 Nov 2010
At a glance
- Drugs Alprostadil/lidocaine (Primary)
- Indications Premature ejaculation
- Focus Therapeutic Use
- Sponsors Apricus Biosciences
- 05 Nov 2010 New trial record.